Cancer Diagnostics Market Analysis 2017 – Global Trends and Forecast to 2024

1. Cancer Diagnostics Market – Global Industry Trends and Forecast to 2024 Global Cancer Diagnostics Market By Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melonoma), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024 Browse Full Report and Details TOC : http://databridgemarketresearch.com/reports/global-cancer-diagnostics-market/

2. Report Description Global Cancer Diagnostics Market is expected to reach USD 18.4 billion by 2024 from USD 7.6 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Key factors propelling growth of this market are technological advancements in the diagnostics imaging systems, growing number of cancer patients globally, rapidly aging population, and huge government support for research in cancer diagnostics. Request Sample Report : http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market

3. Market Segmentation The market is segmented on the basis of technology and application, and geography. The global cancer diagnostics market, by technology, is categorized into two main segments—platform based and instrument-based. The global cancer diagnostics market, by application into lung cancer, breast cancer, colorectal cancer, melanoma and other forms of cancer. Breast cancer diagnosis is expected to hold the largest share of this market in 2015, due to very high prevalence in North America also due to very high cost of mammography instruments. Request for Customization @ sales@databridgemarketresearch.com

4. Regional Analysis • Based on geography the market is segmented into 5 geographical regions, • North America • Europe • Asia-Pacific • South America • Middle East and Africa. • The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.

5. Major Key Players • Major players in the Global Cancer Diagnostics Market are: • Abbott Laboratories, Inc. • ThermoFisher Scientific, Inc. • Illumina, Inc. • Becton, Dickinson and Company • GE Healthcare • QIAGEN N.V. • Agilent Technologies, Inc. • Roche Diagnostics • Siemens Healthcare • Philips Healthcare, and C.R. Bard, Inc., Hologic, Inc. among other players. http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-diagnostics-market

6. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : Ankit Singh+1-888-387-2818 (Toll Free) sales@databridgemarketresearch.com